星形胶质细胞向A1型极化释放C3通过下调UCHL1抑制qNSC激活对脊髓神经再生的阻抑机制研究
批准号:
82071362
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
邓宇斌
依托单位:
学科分类:
神经损伤、修复与再生
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
邓宇斌
中文摘要
脊髓损伤(SCI)是灾难性疾病目前尚无有效疗法。内源性神经干细胞(NSC)无免疫排斥而备受关注。如何激活内源性静息NSC(qNSC)分化为神经元修复SCI是科学难题。预实验表明,SCI后泛素水解酶(UCHL1)被抑制,qNSC中冗余蛋白累积;而在激活态NSC高表达可清除冗余蛋白激活qNSC向神经元分化。上调SCI后UCHL1水平可促进qNSC激活和神经再生。检测SCI微环境发现星形胶质细胞向A1型极化产生C3抑制qNSC激活。科学假说:SCI致星形胶质细胞向A1型极化产生C3抑制NSC中UCHL1,阻碍qNSC中冗余蛋白清除,抑制NSC激活及修复SCI。本项目研究C3抑制Nrf2/UCHL1通路及对下游蛋白酶体亚基作用机制,特异中和抗体阻断星形胶质细胞A1型极化,用LV-UCHl1转染NSC提高UCHL1蛋白水平,清除qNSC冗余蛋白激活NSC促神经再生的机制研究,为SCI治疗提供新思路。
英文摘要
Spinal cord injury (SCI) is a catastrophic disease with no effective treatment currently. Endogenous neural stem cells (NSCs) have attracted much attention due to no immune rejection. How to improve the microenvironment and activate endogenous quiescent NSC (qNSC) to differentiate into neurons to repair SCI is the key problem. Our experiments showed that ubiquitin hydrolase (UCHL1) level was reduced after SCI, resulting in aggresome accumulated in qNSC. However, it was highly expressed in activated NSC and could clear aggresome to activate qNSC to differentiate into neurons. Overexpression of UCHL1 after SCI promoted qNSC activation and nerve regeneration. Analysis of the SCI microenvironment revealed that astrocytes were polarized towards A1 type, and released C3 to inhibit qNSC activation. Thus, we put forward the hypothesis that astrocytes are polarized to A1 type post-SCI, which releases C3 inhibits UCHL1 levels in NSCs, preventing the removal of aggresome in qNSCs and inhibiting NSC activation to repair SCI. In this study, we intend to use the specific neutralizing antibodies to block astrocytes from polarizing to type A1, which restores UCHL expression and clears the aggresome in qNSC to activate its differentiation into neurons, and promote SCI repair; and the role of C3/C3R in UCHL1 and its downstream proteasome subunits will be further illustrated. Our study will provide new ideas for SCI treatment.
脊髓损伤(spinal cord injury,SCI)常导致永久性的神经损伤和感觉运动功能障碍,目前临床尚无较为有效的治疗方法。动员脊髓内源性神经干细胞(neural stem cell,NSC)增殖分化对SCI修复治疗具有重要研究前景,可规避NSC移植存在的伦理争议、致瘤性、免疫排斥等问题。但是,SCI后形成的局部抑制性损伤微环境并不支持内源性NSC的激活和神经元命运分化,从而无法达到有效的神经修复效果。揭示脊髓微环境中调控内源性NSC激活和神经发生的潜在机制对脊髓损伤修复具有重要意义。研究表明胞内蛋白质聚集体的积累可损害静息态NSC的激活能力。泛素 C 端水解酶L1 (Ubiquitin C-terminal Hydrolase L1, UCHL1)是一种在CNS特异性表达的去泛素化酶,在蛋白聚集体清除中起关键作用。本研究发现,SCI后NSC中UCHL1表达下调,在NSC中过表达UCHL1可通过泛素-蛋白酶体途径促进蛋白质聚集体清除而增强其激活增殖和神经元分化。构建大鼠SCI全横断模型,体内应用慢病毒和含Nestin特异性启动子的腺相关病毒靶向上调受损脊髓NSC中的UCHL1,可促进SCI后脊髓NSC激活增殖和神经元分化,并有利于SCI大鼠后肢运动功能恢复。基于SCI脑脊液蛋白芯片分析,进一步发现SCI后脑脊液中补体C3水平升高,而且受损组织中 C3/GFAP+反应性星形胶质细胞显著增多。NSC与反应性星形胶质细胞共培养实验表明反应性星形胶质细胞可通过C3/C3aR信号抑制NSC中UCHL1和蛋白酶体活性,导致蛋白聚集体增加,阻碍NSC增殖。应用中和抗体阻断SCI后反应性星形胶质细胞形成或C3/C3aR通路,均可通过上调UCHL1表达和提升蛋白酶体活性来增强SCI后NSC激活增殖。综上所述,本研究结果确定了UCHL1是脊髓NSC激活的关键调控因子,并初步揭示了反应性星形胶质细胞通过补体C3/C3aR途径抑制UCHL1-酶体功能阻断脊髓内源性NSC激活的新机制,为调控NSC修复脊髓损伤提供了潜在的分子靶点和新思路。
P-选择素高表达通过PSGL-1-PAD4信号通路激活中性粒细胞NETs过度形成致重症急性胰腺炎的机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:邓宇斌
-
依托单位:
纳米基因载体RGD-DMAPA-Amyp负载HIF-1α靶向递送至缺血性脑卒中损伤内皮细胞促血管新生
-
批准号:81571105
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:邓宇斌
-
依托单位:
MSCs在中枢神经损伤模型中向神经元样细胞功能分化的在体MRI示踪研究
-
批准号:30973093
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2009
-
负责人:邓宇斌
-
依托单位:
MSCs诱导为神经元及其在体治疗神经损伤性疾病的研究
-
批准号:30271327
-
项目类别:面上项目
-
资助金额:19.0万元
-
批准年份:2002
-
负责人:邓宇斌
-
依托单位:
HLA-DRα基因反义RNA导入脐血干细胞降低GVHR实验研究
-
批准号:39600156
-
项目类别:青年科学基金项目
-
资助金额:8.0万元
-
批准年份:1996
-
负责人:邓宇斌
-
依托单位:
国内基金
海外基金